Navigation Links
FDA Approves New Treatment for Chronic Hepatitis B

The Food and Drug Administration (FDA) announced the approval of Baraclude (entecavir) tablets and oral solution for the treatment of chronic hepatitis B in adults. Chronic hepatitis B is a serious disease caused by the hepatitis B virus (HBV) that attacks the liver. The virus can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death. According to the Centers for Disease Control and Prevention, approximately 1.25 million Americans are chronically infected with the HBV virus.

Baraclude slows the progression of chronic hepatitis B by interfering with viral reproduction.

FDA based its approval of Baraclude on the results of three studies in which Baraclude was compared to another anti-viral drug, lamivudine.

In all three clinical studies, patients treated with Baraclude showed significant improvement in the liver inflammation caused by HBV and an improvement in the degree of liver fibrosis (scarring). In addition, a higher percentage of patients treated with Baraclude showed significant improvement compared to lamivudine.

The major adverse events associated with the use of Baraclude were of the type typically seen with HBV therapy. They include severe, acute exacerbation of hepatitis B after discontinuation of Baraclude, headache, abdominal pain, diarrhea, fatigue, and dizziness. The labeling for Baraclude states that patients who discontinue Baraclude should be monitored at repeated intervals over a period of time for liver function.

Baraclude's sponsor, Bristol-Myers Squibb Company of Wallingford, Conn., has committed to conducting a large post-marketing study of Baraclude (entecavir) to evaluate the risks of cancers and liver related complications.


'"/>

Source:U.S. FDA


Page: 1

Related biology news :

1. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
2. FDA Approves New Drug to Treat Type I and Type II Diabetes
3. Discovery Could Lead To Novel Approaches In HIV Treatment
4. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
5. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
6. Effective Cancer Treatments Follow The Clock
7. Protein Discovery Could Unlock The Secret To Better TB Treatment
8. Natural Killers Could Lead to New Hepatitis Treatments
9. Study Finds Moderate Hypothermia A Safe Treatment For Traumatic Brain Injury In Kids
10. Drug Offers Alternative to Surgical Treatment After Miscarriage
11. Treatments have same target, different responses for lung cancer patients with genetic mutation
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: FDA Approves New Treatment for Chronic Hepatitis

(Date:5/21/2013)... epigenetic modifications, which alter the way genes function ... be detected in the blood of pregnant women ... to foretell depression in the weeks after giving ... become debilitating. , The findings of the small ... in the journal Molecular Psychiatry . , ...
(Date:5/20/2013)... University of Minnesota Medical School researchers from the Masonic ... University,s Brain Tumor Program, have developed a new mouse ... allow them to discover new genes and gene pathways ... published this week in the journal Nature Genetics ... in the lab of David Largaespada, Ph.D., professor in ...
(Date:5/20/2013)... popularly known as the lungs of the planet, inhales carbon ... the air to grow parts that eventually fall to the ... plentiful rainfall. , Until recently people believed much of ... ended up deep in the ocean. University of Washington research ... carbon dioxide though left open the question of how ...
Breaking Biology News(10 mins):Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3U of M researchers develop model for better testing, targeting of MPNST 2Amazon River exhales virtually all carbon taken up by rain forest 2Amazon River exhales virtually all carbon taken up by rain forest 3
... can alleviate the effects of disorders such as depression ... But because controlling that stimulation currently lacks precision, over-stimulation ... therapeutic benefits for the patient over time. ... European consortium, is delving deep into human behavior, neurophysiology ...
... at Austin will receive up to $19 million from the U.S. ... monitoring plan for a carbon capture and storage demonstration project in ... emissions of the greenhouse gas carbon dioxide (CO 2 ) from ... first in the state of Texas, and one of only a ...
... an engineer charged with designing an SUV to sell ... you consider before creating a prototype? This is ... Catalano,s latest book series, Engineering and Society: Working Towards ... Baillie of the University of Western Australia, encourage engineers ...
Cached Biology News:A pacemaker for your brain 2University receives $19 million to monitor carbon storage project 2University receives $19 million to monitor carbon storage project 3Engineering textbook promotes social justice 2
(Date:5/22/2013)... 22, 2013 Alton Housing Authority was hit ... 2013 said that their presence has already caused the ... sufferers avoid such big spending, My Cleaning Products shared a ... It was said in the report that to clear the ... Apart from that, its employees also attended a mandatory training ...
(Date:5/22/2013)...  Moderna Therapeutics, the pioneering company developing messenger RNA ... in vivo production of therapeutic proteins, announced ... join Moderna in early July as its first Chief ... leader in the design and implementation of information systems ... translation, clinical operations and commercial preparedness. John has also ...
(Date:5/21/2013)... Belmont, MA (PRWEB) May 21, 2013 ... complete tracking to reporting eLearning solution using Tin ... report and dashboard tool. CLD is a leading ... biotech, and medical device companies worldwide. , ... tracking standard that helps learners and trainers more ...
(Date:5/21/2013)... 2013 The congress of the ... is the biggest congress in Europe ... participants are in Istanbul to ... New pioneering studies have been presented: / ... ADMINISTERED VIA HEMODIALYSATE REDUCES ESA USE" By ...
Breaking Biology Technology:Bed Bugs Cost Alton Housing Authority $35,000; New Help, How to Kill Bed Bugs With Less Expense, Introduced by My Cleaning Products 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3
... March 6, 2012 CSL Behring announced today that ... (Human) within six hours of the onset of an ... than later treatment, according to data presented at the 2012 ... While HAE patients treated within six hours of attack onset ...
... Inc. (NASDAQ: CADX ), a biopharmaceutical company ... principally for use in the hospital setting, today announced ... year ended December 31, 2011 financial results on Monday, ... host a conference call and live webcast to discuss ...
... 2012 The manufacturer of the nation,s first ... laboratory tests that refute recent allegations its products ... (Photo:  http://photos.prnewswire.com/prnh/20120305/CL64361 ) ... found formula products manufactured by Nature,s One, Inc. ...
Cached Biology Technology:CSL Behring Study Confirms Early Treatment with Berinert® Provides Faster Resolution of Acute Hereditary Angioedema Symptoms 2CSL Behring Study Confirms Early Treatment with Berinert® Provides Faster Resolution of Acute Hereditary Angioedema Symptoms 3CSL Behring Study Confirms Early Treatment with Berinert® Provides Faster Resolution of Acute Hereditary Angioedema Symptoms 4Arsenic Testing Proves Organic Baby Formula Safe 2
Rabbit polyclonal to Phosphothreonine-Proline / Phosphoserine-Proline ( Abpromise for all tested applications)....
Request Info...
Rabbit polyclonal to Glutathione S Transferase alpha ( Abpromise for all tested applications). Antigen: Full length protein: Human Glutathione S Transferase alpha. Entrez GeneID: 2938 Swi...
Affinity Purified Rabbit Anti-mouse sRANKL Biotinylated Polyclonal Antibody...
Biology Products: